5-Bromo-2-[(4'-chloro-3'-nitrophenyl)sulfonyl]amino-N-(2',5'-dichlorophenyl) benzamide | 136402-20-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 5-Bromo-2-[(4'-chloro-3'-nitrophenyl)sulfonyl]amino-N-(2',5'-dichlorophenyl) benzamide
• 英文别名: 5-bromo-2-{[(4-chloro-3-nitrophenyl)sulfonyl]amino}-N-(2,5-dichlorophenyl)benzamide；5-bromo-2-[(4-chloro-3-nitrophenyl)sulfonylamino]-N-(2,5-dichlorophenyl)benzamide
• CAS: 136402-20-5
• 化学式: C₁₉H₁₁BrCl₃N₃O₅S
• 分子量: 579.642
• InChiKey: SWNIGAHTYOZSDW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.2
• 重原子数：
  32
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  130
• 氢给体数：
  2
• 氢受体数：
  6

文献信息

• Phosphate transport inhibitors
  申请人：GelTex Pharmaceuticals, Inc.

  公开号：US20040019113A1

  公开（公告）日：2004-01-29

  Disclosed are compounds which have been identified as inhibitors of phosphate transport. Many of the compounds are represented by Structural Formula (I): Ar 1 —W—X—Y—Ar 2 ; or a pharmaceutically acceptable salt thereof. Ar 1 and Ar 2 are independently a substituted or unsubstituted aryl group or an optionally substituted five membered or six membered non-aromatic heterocylic group fused to an optionally substituted monocylic aryl group. W and Y are independently a covalent bond or a C1-C3 substituted or unsubstituted alkylene group. X is a heteroatom-containing functional group, an aromatic heterocyclic group, substituted aromatic heterocyclic group, non-aromatic heterocyclic group, substituted non-aromatic heterocyclic group, an olefin group or a substituted olefin group. Also disclosed are methods of treating a subject with a disease associated with hyperphosphatemia, as well as a disease mediated by phosphate-transport function. The methods comprise the step of administering an effective amount of the one of the compounds described above.

  本文披露了被识别为磷酸盐转运抑制剂的化合物。许多化合物由结构式(I)表示：Ar1—W—X—Y—Ar2；或其药用可接受的盐。Ar1和Ar2独立地是取代或未取代的芳基或可取代的五元或六元非芳香杂环基与可取代的单环芳基融合。W和Y独立地是共价键或C1-C3取代或未取代的烷基基团。X是含杂原子的官能团、芳香杂环基、取代芳香杂环基、非芳香杂环基、取代非芳香杂环基、烯烃基或取代烯烃基。还披露了治疗与高磷血症相关疾病以及磷酸盐转运功能介导的疾病的方法。该方法包括给予上述化合物之一的有效量。
• PHOSPHATE TRANSPORT INHIBITORS
  申请人：GENZYME CORPORATION

  公开号：EP1465638A2

  公开（公告）日：2004-10-13
• METHODS FOR TREATMENT OF MICROCEPHALY ASSOCIATED AUTISM DISORDERS
  申请人：BROWN UNIVERSITY

  公开号：US20160193296A1

  公开（公告）日：2016-07-07

  The invention features methods for the treatment of one or more symptoms of microcephaly associated autism disorders e.g., Christianson syndrome, by administering agents that increase the level or activity of BDNF or TrkB in the brain of the patient. These agents may include BDNF, a BDNF agonist, a BDNF mimetic, a TrkB agonist, a cell expressing recombinant BDNF, a BDNF encoding recombinant nucleic acid molecule encapsidated within a recombinant virus, and an agent that decreases the acidity of endosomes.
• COMPOSITIONS AND METHODS FOR ENHANCING GENOME EDITING
  申请人：The Regents of the University of California

  公开号：US20200115688A1

  公开（公告）日：2020-04-16

  The present disclosure provides a composition comprising an RNA-guided endonuclease and an agent that decreases the acidity of an endosome. The present disclosure provides a composition comprising: a) a ribonucleoprotein (RNP) complex comprising: i) an RNA-guided endonuclease; and ii) a guide RNA comprising a segment that binds to the RNA-guided endonuclease and a segment that binds to a target nucleic acid; and b) an agent that decreases the acidity of an endosome. The present disclosure provides methods of binding a target nucleic acid in a eukaryotic cell; and methods of genetically modifying a target eukaryotic cell.
• US7119120B2
  申请人：——

  公开号：US7119120B2

  公开（公告）日：2006-10-10